Opinion
Video
Author(s):
Turning the focus to ibrutinib-based therapy, Yuliya Linhares, MD, gives an overview of the RESONATE study.
Brukinsa Shows Favorable Safety Profile Over Imbruvica in CLL
A Chance of Cure for Cervical Cancer, Lymphedema Treatment Act and More
Why Hope is Important For Patients with Chronic Lymphocytic Leukemia
The Treatment Journey of a Patient with CLL
Waiting for Results After My CLL Diagnosis
Learning to ‘Let it Be’ After Poor Test Results